Doctor profile · Federal record
Dr. Barry Resnik, M.D.
Dermatology Physician (CMS: Dermatology) · Aventura, FL
- NPI 1336148535
- Accepts Medicare
- MIPS 0.0 / 100 · 2023
- 36 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
21097 Ne 27Th CT Ste 580
Aventura, FL 331801246
(305) 692-8998
fax (305) 692-8606
Credentials & registration
- NPI registered
- July 2005 — 21 yrs on file
- Profile last updated
- January 31, 2023
- Year of graduation
- 1990 — 36 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Florida #ME60934
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1336148535. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,331
Distinct HCPCS
10
Medicare allowed
$78,864
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 331 | 218 | $96 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 221 | 43 | $1 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 196 | 35 | $7 | |
11102 |
Biopsy of related skin growth, first growth | 106 | 86 | $103 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 105 | 75 | $60 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 86 | 86 | $122 | |
96372 |
Injection of drug or substance under skin or into muscle | 78 | 28 | $15 | |
17000 |
Destruction of precancer skin growth, 1 growth | 63 | 49 | $57 | |
11103 |
Biopsy of related skin growth, each additional growth | 45 | 30 | $53 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 29 | 25 | $134 |
In context: peer comparison
Among 9 peers in Aventura Dermatology Physician, average services per provider: 189. This provider delivers 7.0× the peer median.Open Payments
Industry payments received
All-time total
$13,187
Transactions
61
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 16 | $6,430.35 | |
| Novartis Pharmaceuticals Corporation | 15 | $6,002.65 | |
| Janssen Biotech, INC. | 9 | $209.26 | |
| Ucb, INC. | 5 | $163.45 | |
| Genzyme Corporation | 2 | $74.61 | |
| Dermavant Sciences, INC. | 2 | $61.14 | |
| Pfizer INC. | 3 | $59.28 | |
| Smith+Nephew, INC. | 2 | $51.64 | |
| Organon LLC | 2 | $31.54 | |
| Incyte Corporation | 1 | $28.41 | |
| Leo Pharma INC. | 1 | $22.29 | |
| Teva Pharmaceuticals USA, INC. | 1 | $19.88 | |
| Galderma Laboratories, L.P. | 1 | $18.74 | |
| Hartmann USA, INC. | 1 | $13.33 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
449
Patients
128
Total drug cost
$888,592
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 79 | 48 | $653 |
| Ketoconazole | Generic | 55 | 19 | $1,508 |
| Ertapenem (Ertapenem Sodium) | Brand | 36 | 0 | $22,170 |
| Remicade (Infliximab) | Brand | 31 | 0 | $361,647 |
| Sodium Chloride (0.9 % Sodium Chloride) | Brand | 31 | 0 | $129 |
| Mometasone Furoate | Generic | 30 | 0 | $1,016 |
| Clindamycin Phosphate | Generic | 27 | 15 | $762 |
| Cosentyx Sensoready (2 Pens) (Secukinumab) | Brand | 27 | 0 | $240,608 |
| Terbinafine Hcl | Generic | 22 | 14 | $269 |
| Doxycycline Hyclate | Generic | 21 | 0 | $1,538 |
Frequently asked questions
What is Dr. Barry Resnik's medical specialty?
Dr. Barry Resnik practices Dermatology Physician in Aventura, FL.
Where does Dr. Barry Resnik practice?
Dr. Barry Resnik practices at 21097 Ne 27Th CT Ste 580, Aventura, FL 331801246. Office phone: 3056928998.
What is Dr. Barry Resnik's NPI?
Dr. Barry Resnik's National Provider Identifier (NPI) is 1336148535, issued by NPPES.
Does Dr. Barry Resnik accept Medicare assignment?
Yes. Dr. Barry Resnik accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Barry Resnik commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS J3301); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003). Source: CMS Medicare Physician & Other Practitioners file.